Furthermore, a clinical study revealed that a distinct NOD2 gene mutation (homozygous for the 3020insC mutation) observed in Crohn’s disease patients leads to massive TNF-α release by TLR-4 activation via LOS or LPS [156], indicating that a mutation in the NOD2 gene is associated with increased LOS susceptibility. The gene discussed is NOD2; the disease is Crohn disease.